Role of macrophage cytokines in mucosal adjuvanticity

Advances in Veterinary Medicine

Volumn 41, Issue C, 1999, Pages 83-104

  Foss, Dennis L ^a   Murtaugh, Michael P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; CYTOKINE; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; INTERLEUKIN 12;

ANIMAL; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; MACROPHAGE; MUCOSAL IMMUNITY; NATURAL KILLER CELL; REVIEW; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHOLERA TOXIN; CYTOKINES; HUMANS; IMMUNITY, MUCOSAL; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-12; INTESTINAL MUCOSA; KILLER CELLS, NATURAL; MACROPHAGES; T-LYMPHOCYTES;

EID: 0032621098     PISSN: 1093975X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3519(99)80010-X     Document Type: Chapter

References (67)

1. Agren L.C., Ekman L., Lowenadler B., and Lycke N.Y. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J. Immunol. 158 (1997) 3936-3946
2. Bergquist C., Johansson E.L., Lagergard T., Holmgren J., and Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 65 (1997) 2676-2684
3. Blecha F., Reddy D.N., Chitko-McKown C.G., Mcvey D.S., Chengappa M.M., Goodband R.D., and Nelssen J.L. Influence of recombinant bovine interleukin-1 beta and interleukin-2 in pigs vaccinated and challenged with Streptococcus suis. Vet. Immunol. Immunopathol. 44 (1995) 329-346
4. Bost K.L., and Clements J.D. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect. Immun. 63 (1995) 1076-1083
5. M1 with the B subunit of cholera toxin. Biochim. Biophys. Acta 1256 (1995) 275-283
6. Chandra G., Cogswell J.P., Miller L.R., Godlevski M.M., Stinnett S.W., Noel S.L., Kadwell S.H., Kost T.A., and Gray J.G. Cyclic AMP signaling pathways are important in IL-1 beta transcriptional regulation. J. Immunol. 155 (1995) 4535-4543
7. Clemens D., Sack D.A., Chakraborty J., Rao M.R., Ahmed F., Harris J.R., van Loon F.P.L., Khan M.R., Yunis M., and Huda S. Field trial of oral cholera vaccines in Bangladesh: Evaluation of anti-bacterial and anti-toxin breast-milk immunity in response to ingestion of the vaccine. Vaccine 8 (1990) 469-472
8. Clemens J.D., Stanton B.F., Chakraborty J., Sack D.A., Khan M.R., Huda S., Ahmed F., Harris J.R., Yunus M., Khan M.U., Svennerholm A.M., Jertborn M., and Holmgren J. B subunit-whole cell and whole cell-only vaccines against cholera: Studies on reactivity and immunogenicity. J. Infect. Dis. 155 (1987) 79-85
9. deHaan L., Holtrop M., Verweij W.R., Agsteribbe E., and Wilschut J. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: Role of the A subunit. Vaccine 14 (1996) 260-266
10. deHaan L., Verweij W.R., Feil I.K., Lijnema T.H., Hol W.G.J., Agsteribbe E., and Wilschut J. Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity retain the immunogenic properties of the native holotoxin. Infect. Immun. 64 (1996) 5413-5416
11. Elson C.O., and Ealding W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132 (1984) 2736-2741
12. Elson C.O., Holland S.P., Dertzbaugh M.T., Cuff C.F., and Anderson A.O. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J. Immunol. 154 (1995) 1032-1040
13. Finkelman F.D., Madden K.B., Cheever A.W., Katona I.M., Morris S.C., Gately M.K., Hubbard B.R., Gause W.C., and Urban J.F. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179 (1994) 1563-1572
14. Francis M.L., Okazaki I., Moss J., Kurosky A., Pecanha L.M.T., and Mond J.J. cAMP-independent effects of cholera toxin on B cell activation. III. Choleratoxin a subunit-mediated ADP-ribosylation acts synergistically with ionomycin or IL-4 to induce B cell proliferation. J. Immunol. 154 (1995) 4956-4964
15. Grohmann U., Bianchi R., Ayroldi E., Belladonna M.L., Surace D., Fioretti M.C., and Puccetti P. A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state. J. Immunol. 158 (1997) 3593-3602
16. Gyles C.L., and Barnum D.A. A heat-labile enterotoxin from strains of Escherichia coli enteropathogenic for pigs. J. Infect. Dis. 120 (1969) 419-426
17. Heinzel F.P., Hujer A.M., Ahmed F.N., and Rerko R.M. In vivo production and function of IL-12 p40 homodimers. J. Immunol. 158 (1997) 4381-4388
18. Holmgren J., Czerkinsky C., Sun J., and Svennerholm A.M. Oral vaccination, mucosal immunity and oral tolerance with special reference to cholera toxin. In: Kaufmann S.T.E. (Ed). Concepts in Vaccine Development (1996), de Gruyter, New York 437-458
19. Hunter C.A., Chizzonite R., and Remington J.S. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells-A role for IL-1 beta in the T cell-independent mechanisms of resistance against intracellular pathogens. J. Immunol. 155 (1995) 4347-4354
20. Jackson R.J., Marinaro M., VanCott J.L., Yamamoto M., Okahashi N., Fujihashi K., Kiyono H., Chatfield S.N., and McGhee J.R. Mucosal immunity: Regulation by helper T cells and a novel method for detection. J. Biotechnol. 44 (1996) 209-216
21. Jenkins M.K., Chen C., Jung G., Mueller D.L., and Schwartz R.H. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monclonal antibody. J. Immunol. 144 (1991) 16-22
22. Jertborn M., Svennerholm A.M., and Holmgren J. Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immunization with B subunit-whole cell cholera vaccine. Int. Arch. Allergy Appl. Immunol. 75 (1986) 38-43
23. Johnson J.G., and Jenkins M.K. Minireview: The role of anergy in peripheral T cell unresponsiveness. Life Sci. 55 (1994) 1767-1780
24. Kincycain T., and Bost K.L. Increased susceptibility of mice to salmonella infection following in vivo treatment with the substance P antagonist, spantide II. J. Immunol. 157 (1996) 255-264
25. Kincycain T., and Bost K.L. Substance P-induced IL-12 production by murine macrophages. J. Immunol. 158 (1997) 2334-2339
26. Kincycain T., Clements J.D., and Bost K.L. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect. Immun. 64 (1996) 1437-1440
27. Kochnolte F., Haag F., Kastelein R., and Bazan F. Uncovered-The family relationship of a T-cell-membrane protein and bacterial toxins. Immunol. Today 17 (1996) 402-405
28. Krakauer T. Evidence for protein kinase C pathway in the response of human peripheral blood mononuclear cells to cholera toxin. Cell. Immunol. 172 (1996) 224-228
29. Loftager M.K., Elmerdahl-Olsen J., and Eriksen L. Immune reaction of pigs following intra-gastric or ileal inoculation of attenuated Salmonella typhi. Adv. Exp. Med. Biol. 371B (1995) 913-917
30. Lycke N.Y. Cholera toxin promotes B cell isotype switching by two different mechanisms: cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation. J. Immunol. 150 (1993) 4810-4821
31. Lycke N., and Holmgren J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59 (1986) 301-308
32. Lycke N., and Strober W. Cholera toxin promotes B cell isotype differentiation. J. Immunol. 142 (1989) 3781-3787
33. Lycke N., Bromander A., Ekman L., Karlsson U., and Holmgren J. Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J. Immunol. 142 (1989) 20-27
34. Lycke N., Bromander A.K., and Holmgren J. Role of local IgA antitoxin-producing cells for intestinal protection against cholera toxin challenge. Int. Arch. Allergy Appl. Immunol. 88 (1989) 273-279
35. Lycke N., Severinson E., and Strober W. Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation. J. Immunol. 145 (1990) 3316-3324
36. Lycke N., Karlsson U., Sjolander A., and Magnusson K.E. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand. J. Immunol. 33 (1991) 691-698
37. Ma X.J., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.E., Dzialo R., and Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183 (1996) 147-157
38. Mansfield L.S., Urban J.F., Murtaugh M.P., Zarlenga D.S., Foss D.L., and Lunney J.K. Development of IL-10, IL-12 and HPRT internal cDNA competetors for measuring swine cytokine gene expression by quantitative RT-PCR. Conf. Res. Workers Anim. Dis. Proc. 76 (1995) 131
39. Marinaro M., Staats H.F., Hiroi T., Jackson R.J., Coste M., Boyaka P.N., Okahashi N., Yamamoto M., Kiyono H., Bluethmann H., Fujihashi K., and McGhee J.R. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155 (1995) 4621-4629
40. Marinaro M., Kiyono H., van Cott J.L., Okahashi N., van Ginkel F.W., Pascual D.W., Ban E., Jackson R.J., Staats H.F., and McGhee J.R. Vaccines for selective induction of Th-1 and Th2-cell responses and their roles in mucosal immunity. In: Kagnoff M.F., and Kiyono H. (Eds). Essentials of Mucosal Immunology (1997), Academic Press, San Diego, CA 461-475
41. Mastroeni P., Harrison J.A., Chabalgoity J.A., and Hormaeche C.E. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect. Immun. 64 (1996) 189-196
42. Matousek M.P., Nedrud J.G., and Harding C.V. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages. J. Immunol. 156 (1996) 4137-4145
43. Monteleone G., Biancone L., Marasco R., Morrone G., Marasco O., Luzza F., and Pallone F. Interleukin 12 is expressed and actively released by Crohns disease intestinal lamina propria mononuclear cells. Gastroenterology 112 (1997) 1169-1178
44. Nakagawa I., Takahashi I., Kiyono H., McGhee J.R., and Hamada S. Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches. J. Infect. Dis. 173 (1996) 1428-1436
45. Nashar T.O., Hirst T.R., and Williams N.A. Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin-Receptor interaction up-regulates MHC class II, B7, CD40, CD25 and ICAM-1. Immunology 91 (1997) 572-578
46. Pape K.A., Khoruts A., Mondino A., and Jenkins M.K. Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4(+) T cells. J. Immunol. 159 (1997) 591-598
47. Pappo J., and Mahlman R.T. Follicle epithelial M cells are a source of interleukin-1 in Peyer's patches. Immunology 78 (1993) 505-507
48. Pierce N.F. The role of antigen form and function in the primary and secondary intestinal immune response to cholera toxin and toxoid in rats. J. Exp. Med. 148 (1978) 195-200
49. Pierce N.F., Cray W.C., and Engel P.F. Antitoxic immunity to cholera in dogs immunized orally with cholera toxin. Infect. Immun. 27 (1980) 632-637
50. Pierre P.G., Mbongolo Mbella E.G., and Vaerman J.P. Effect of cholera toxin and its B subunit on intestinal permeability for ovalbumin. Adv. Exp. Med. Biol. 371B (1995) 1519-1521
51. Podlaski F.J., Nanduri V.B., Hulmes J.D., Pan Y.C., Levin W., Danho W., Chizzonite R., Gately M.K., and Stern A.S. Molecular characterization of interleukin 12. Arch. Biochem. Biophys. 294 (1992) 230-237
52. Reed S.G., Pihl D.L., Conlon P.J., and Grabstein K.H. IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha. J. Immunol. 142 (1989) 3129-3133
53. Schwartz R.H. Models of T cell anergy-Is there a common molecular mechanism. J. Exp. Med. 184 (1996) 1-8
54. Sieburth D., Jabs E.W., Warrington J.A., Li X., Lasota J., LaForgia S., Kelleher K., Huebner K., Wasmuth J.J., and Wolf S.F. Assignment of genes encoding a unique cytokine (IL-12) composed of two unrelated subunits to chromosomes 3 and 5. Genomics 14 (1992) 59-62
55. Snider D.P. The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit. Rev. Immunol. 15 (1995) 317-348
56. Snijders A., Hilkens C.M.U., Kraan T.C.T.M.V., Engel M., Aarden L.A., and Kapsenberg M.L. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156 (1996) 1207-1212
57. Sone S., Orino E., Mizuno K., Yano S., Nishioka Y., Haku T., Nii A., and Ogura T. Production of IL-1 and its receptor antagonist is regulated differently by IFN gamma and IL-4 in human monocytes and alveolar macrophages. Eur. Respir. J. 7 (1994) 657-663
58. Spangler B.D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56 (1992) 622-647
59. Svennerholm A.M., Jertborn M., Gothefors L., Karim A.M.M.M., Sack D.A., and Holmgren J. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149 (1984) 884-893
60. Tone Y., Thompson S.A.J., Babik J.M., Nolan K.F., Tone M., Raven C., and Waldmann H. Structure and chromosomal location of the mouse interleukin-12, p35 and p40 subunit genes. Eur. J. Immunol. 26 (1996) 1222-1227
61. Urban J.F., Fayer R., Chen S.J., Gause W.C., Gately M.K., and Finkelman F.D. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J. Immunol. 156 (1996) 263-268
62. Vajdy M., Kosco-Vilbois M.H., Kopf M., Kohler G., and Lycke N. Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181 (1995) 41-53
63. Vella A.T., Mitchell T., Groth B., Linsley P.S., Green J.M., Thompson C.B., Kappler J.W., and Marrack P. CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. J. Immunol. 158 (1997) 4714-4720
64. Wassen L., Schon K., Holmgren J., Jertborn M., and Lycke N. Local intravaginal vaccination of the female genital tract. Scand. J. Immunol. 44 (1996) 408-414
65. Weigle W.O., Scheuer W.V., Hobbs M.V., Morgan E.L., and Parks D.E. Modulation of the induction and circumvention of immunological tolerance to human gamma-globulin by interleukin 1. J. Immunol. 138 (1987) 2069-2074
66. Wilson A.D., Clark C.J., and Stokes C.R. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response in mice to keyhole limpet haemocyanin. Scand. J. Immunol. 31 (1990) 443-451
67. Xuamano J.C., Jackson R.J., Fujihashi K., Kiyono H., Staats H.F., and McGhee J.R. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12 (1994) 903-911